Generic name:elapegademase-lvlr
Dosage form: injection
Drug class:Other immunostimulants
Medically reviewed by Drugs.com. Last updated on Apr 1, 2021.
On This Page
- Indications and Usage
- Dosage and Administration
- Dosage Forms and Strengths
- Contraindications
- Warnings and Precautions
- Adverse Reactions/Side Effects
- Drug Interactions
- Use In Specific Populations
- Overdosage
- Description
- Clinical Pharmacology
- Nonclinical Toxicology
- Clinical Studies
- How Supplied/Storage and Handling
- Patient Counseling Information
Indications and Usage for Revcovi Injection
REVCOVI is indicated for the treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID) in pediatric and adult patients.
Revcovi Injection Dosage and Administration
Recommended Dosage
Patients transitioning from Adagen to REVCOVI
If a patient's weekly Adagen dose is unknown, or a patient's weekly Adagen dose is at or lower than 30 U/kg, the recommended minimum starting dose of REVCOVI is 0.2 mg/kg, intramuscularly, once a week.
If a patient's weekly Adagen dose is above 30 U/kg, an equivalent weekly REVCOVI do...
